Qura srl

Based in Italy, Qura Srl provides a preventative health management solution through a subscription model, offering personalized medical consultations and laboratory analyses for its users. Founded in 2025 in Bologna, Italy, Qura Srl focuses on delivering health management services. The company has not reported any operational pivots. The founder's background is not specified.

In March 2026, Qura Srl raised EUR 1. 5 million in pre-seed funding led by United Ventures, with participation from Vento and Italian Angels for Growth. This funding is the total amount raised, primarily aimed at expanding their team and developing their artificial intelligence preventative health platform. Qura offers a comprehensive health management solution centered around a subscription-based model that provides users with access to personalized medical consultations and laboratory analyses.

The core product is an annual health check-up that includes a blood test assessing over 60 health parameters, facilitated via partnerships with more than 190 clinics. Users select a partner laboratory to conduct their tests without needing a doctor's prescription, allowing them to monitor their health proactively. A dedicated medical professional reviews the results in the context of the user's medical history and health goals, creating personalized health plans to address identified imbalances or concerns. Qura primarily targets the Italian market, serving a diverse clientele that includes individuals seeking to improve their health and well-being through proactive monitoring and tailored interventions.

Qura generates revenue through a subscription-based model with different membership tiers tailored to varying consumer needs. The flagship offering, labeled as the "Complete" plan, allows users to engage in a full range of medical assessments and follow-up consultations at an annual cost of EUR 365, equivalent to EUR 1 per day. In addition to this, the "Base" membership, priced at EUR 149 annually, caters to individuals who prefer to manage their testing independently and at their own expense. The transaction structure is direct-to-consumer, where customers subscribe to access Qura's health services and receive ongoing medical advice and follow-up consultations via an online platform.

This model emphasizes affordability and accessibility to high-quality health management, making it an attractive option for individuals looking to enhance their health proactively. In March 2026, Qura Srl secured EUR 1. 5 million in pre-seed funding, which will be utilized to expand its team and develop an artificial intelligence preventative health platform. The company plans to explore new product offerings designed with advanced technology, although specific release dates are not detailed.

There are also intentions to expand into new markets, which have yet to be specified.